Our interest in studying the effect of glutamine supplementation on astrogliosis in our murine model of SSADHD stems from evidence that astrogliosis is associated with downregulation of glutamine synthetase and increased neuronal excitability, a potential epileptogenic factor.33, 34. Here, GLUL is linked to succinic semialdehyde dehydrogenase deficiency.